What Can You Expect at the Premier GPCR Forum in 2026?
With GPCR investment surging and multi-billion-dollar deals redefining the competitive landscape, the race is on to unlock new receptors and modalities.
The 5th GPCR-Targeted Drug Discovery Summit delivers:
- Exclusive perspectives
- Never-seen-before data
- Practical strategies from teams leading the field
Gain actionable insights to accelerate GPCR therapeutics discovery and stay ahead of industry momentum.
Top Sessions for 2026:
Harnessing AI & ML for Smarter GPCR Drug Discovery
Insights from: Nabla Bio,Biagon, Eli Lilly, Iambic Therapeutics and more
Advancing Next-Generation Antibody and Peptide Approaches
Insights from: Skymab Biotherapeutics, Confo Therapeutics, GSK more
Optimizing Translational Strategies for Clinical Impact
Insights from: Tectonic Therapeutics, Atai Life Sciences, Domain Therapeutics and more
Interrogating the Functional Significance of GPCR Signaling
Insights from: InterAx Biotech, Northeastern University and more
Explore The Full Event Guide
- 80+ Attendees
- 25+ World-Class Speakers
- 21+ Data-Driven Presentations
- 7+ Hours of Networking
- 1 AI & ML Focus Day
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug discovery and make critical connections during our dedicated networking sessions
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.